Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:29 PM
Ignite Modification Date:
2025-12-24 @ 3:29 PM
NCT ID:
NCT02693392
Eligibility Criteria:
Inclusion Criteria:
* Patients suffering from Type-2 Diabetes of less than 10 years duration
* Patients with HbA1c \>7.0%
* Patients with fasting plasma glucose not exceeding 180 mg/dL
* Patients with Negative Urine sugar
* Patients who are on oral hypoglycaemic agents containing either Metformin or Sulfonylurea or both
* There should not be any change their in anti-diabetic treatment for at least one month
Exclusion Criteria:
* Patients with diabetes other than type-2 diabetes mellitus
* Patients with evidence of renal disease (S. Creatinine \> 1.5mg/dL)
* Patients with evidence of liver disease (AST/ALT \>3 times of normal
* Pregnant and lactating mothers and women intending pregnancy
* Patients who participated in any other clinical trial within the last 30 days
* Patients with history of any hemoglobinopathy
* History of intolerance or hypersensitivity to Fenugreek
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
65 Years
Study:
NCT02693392
Study Brief:
Protocol Section:
NCT02693392